Richard Barker has become executive chairman of the board of directors of New Haven, Conn.-based Molecular Staging. Previously, he was CEO of Chiron Diagnostics and general manager of IBM’s health care solutions business. Before that, he led the pharmaceutical practice in Europe for McKinsey. Barker holds a BA in chemistry and a doctorate in biophysics from the University of Oxford in England.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
Not ready for premium?
Register for Free ContentYou can still register for access to our free content.